Literature DB >> 14521274

P300 (latency) event-related potential: an accurate predictor of memory impairment.

Eric R Braverman1, Kenneth Blum.   

Abstract

To determine if P300 latency changes precede and correlate with memory and mental status, patients (N=1506 aged 20-100 years) who received medical and psychiatric diagnoses (from 1997 to 2002), were assessed for P300 (N=1496), WMS-III (N=694), and MMSE (N=456). Patient and control groups included, a) normal WMS-III on all 4 subscales (N=36), b) normal WMS-III and MMSE (N=189) with subjective memory/mental status complaints, and c) medical patients with normal WMS-III and no memory complaints (N=205), and d) P300 control group without medical, psychiatric or memory problems for ROC. Patients with impaired/borderline memory had a prolonged P300 latency (P<0.02) compared to age matched non-impaired controls; in patients with normal WMS-III/MMSE, with subjective mild memory/mental status impairment, P300 latency was prolonged compared to controls (P=0.0004). The P300 latency increased by 0.72ms per year (P=7.9x10(-65)) and voltage decreased by 0.03dV per year (P=6.7x10(-10)), and both parameters were linearly correlated with the age of the subjects. Male subjects had an average voltage of 6.1dV and female 6.8dV (P=0.00009). Statistically, prolonged latency began at age range 41-50 (P=0.0002); reduced P300 voltage began at age range 51-60 (P=0.003). WMS-III memory decline for all measures began in females at age range 61-70 (P value at least=0.02) and for males at age range 61-80 (P=0.02). Prolonged P300 latency (P<0.0001) and memory impairment (at least <0.02) were greater for females than males. MMSE memory decline, male and female, began at age range 81-90 (P value of at least 0.00007). In our logistic regression model P300 latency was more predictive of WMS-III impairment than MMSE > 24. In patients whose WMS-III score is impaired < or = 69, or borderline < or = 79 (P at least=0.004), a P300 latency more prolonged than the norm (> or = 300 + 30 + Age) identifies these patients, whereas a MMSE > 24 failed. With the ROC curve, we confirmed that P300 latency could accurately identify borderline/impaired memory.

Entities:  

Mesh:

Year:  2003        PMID: 14521274     DOI: 10.1177/155005940303400306

Source DB:  PubMed          Journal:  Clin Electroencephalogr        ISSN: 0009-9155


  13 in total

1.  Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Authors:  Eric R Braverman; Thomas J H Chen; Thomas J Prihoda; William Sonntag; Brian Meshkin; B William Downs; Julie F Mengucci; Seth H Blum; Alison Notaro; Vanessa Arcuri; Michael Varshavskiy; Kenneth Blum
Journal:  Age (Dordr)       Date:  2007-05-12

2.  Test of variables of attention (TOVA) as a predictor of early attention complaints, an antecedent to dementia.

Authors:  Eric R Braverman; Amanda Lih-Chuan Chen; Thomas J H Chen; John D Schoolfield; Alison Notaro; Dasha Braverman; Mallory Kerner; Seth H Blum; Vanessa Arcuri; Michael Varshavskiy; Uma Damle; B William Downs; Roger L Waite; Marlene Oscar-Berman; John Giordano; Kenneth Blum
Journal:  Neuropsychiatr Dis Treat       Date:  2010-10-15       Impact factor: 2.570

3.  Cognitive processing of cluster headache patients: evidence from event-related potentials.

Authors:  Rongfei Wang; Zhao Dong; Xiaoyan Chen; Ruozhuo Liu; Mingjie Zhang; Jinglong Wu; Shengyuan Yu
Journal:  J Headache Pain       Date:  2014-10-02       Impact factor: 7.277

4.  Developing Brain Vital Signs: Initial Framework for Monitoring Brain Function Changes Over Time.

Authors:  Sujoy Ghosh Hajra; Careesa C Liu; Xiaowei Song; Shaun Fickling; Luke E Liu; Gabriela Pawlowski; Janelle K Jorgensen; Aynsley M Smith; Michal Schnaider-Beeri; Rudi Van Den Broek; Rowena Rizzotti; Kirk Fisher; Ryan C N D'Arcy
Journal:  Front Neurosci       Date:  2016-05-12       Impact factor: 4.677

5.  Improvement of long-term memory access with a pro-dopamine regulator in an elderly male: Are we targeting dopamine tone?

Authors:  Thomas McLaughlin; David Han; James Nicholson; Bruce Steinberg; Kenneth Blum; Marcelo Febo; Eric Braverman; Mona Li; Lyle Fried; Rajendra Badgaiyan
Journal:  J Syst Integr Neurosci       Date:  2017-06-17

6.  Cholinergic Mechanisms of Target Oddball Stimuli Detection: The Late "P300-Like" Event-Related Potential in Rats.

Authors:  A Ahnaou; R Biermans; W H I M Drinkenburg
Journal:  Neural Plast       Date:  2018-10-16       Impact factor: 3.599

7.  Age-related increases in parathyroid hormone may be antecedent to both osteoporosis and dementia.

Authors:  Eric R Braverman; Thomas J H Chen; Amanda L C Chen; Vanessa Arcuri; Mallory M Kerner; Anish Bajaj; Javier Carbajal; Dasha Braverman; B William Downs; Kenneth Blum
Journal:  BMC Endocr Disord       Date:  2009-10-13       Impact factor: 2.763

8.  Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patients.

Authors:  Eric R Braverman; Kenneth Blum; Uma J Damle; Mallory Kerner; Kristina Dushaj; Marlene Oscar-Berman
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

9.  Preliminary investigation of plasma levels of sex hormones and human growth factor(s), and P300 latency as correlates to cognitive decline as a function of gender.

Authors:  Eric R Braverman; Thomas J H Chen; Amanda L C Chen; Mallory M Kerner; Howard Tung; Roger L Waite; John Schoolfield; Kenneth Blum
Journal:  BMC Res Notes       Date:  2009-07-07

10.  Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients.

Authors:  Eric R Braverman; Kenneth Blum; Karl L Hussman; David Han; Kristina Dushaj; Mona Li; Gabriela Marin; Rajendra D Badgaiyan; Richard Smayda; Mark S Gold
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.